Page last updated: 2024-08-26

mci 9038 and Brain Thrombosis

mci 9038 has been researched along with Brain Thrombosis in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (60.00)	29.6817
2010's	1 (20.00)	24.3611
2020's	1 (20.00)	2.80

Authors

Authors	Studies
Bergis, B; Chanson, N; Chassin, O; Drouot, S; Gleizes, O; Legris, N; Proulle, V; Ract, C; Walle, EM; Werner, M	1
Fushimi, K; Horiguchi, H; Matsubara, T; Nakajima, S; Wada, T; Yahagi, N; Yasunaga, H	1
Ikoma, H	1
Bozzo, J; Escolar, G; Maragall, S	1
Fudaba, H; Hayashida, O; Nagamitsu, T; Nagatsuna, T; Wakuta, Y; Yamashita, T	1

Reviews

2 review(s) available for mci 9038 and Brain Thrombosis

Article	Year
Development of argatroban as an anticoagulant and antithrombin agent in Japan. Pathophysiology of haemostasis and thrombosis, 2002, Volume: 32 Suppl 3 Topics: Anticoagulants; Arginine; Arterial Occlusive Diseases; Humans; Intracranial Thrombosis; Japan; Pipecolic Acids; Product Surveillance, Postmarketing; Renal Dialysis; Sulfonamides; Thrombin	2002
Argatroban: a direct thrombin inhibitor with reliable and predictable anticoagulant actions. Drugs of today (Barcelona, Spain : 1998), 2006, Volume: 42, Issue:4 Topics: Animals; Anticoagulants; Arginine; Blood Coagulation; Drug Monitoring; Humans; Intracranial Thrombosis; Pipecolic Acids; Randomized Controlled Trials as Topic; Stroke; Sulfonamides; Thrombin; Thrombocytopenia	2006

Trials

1 trial(s) available for mci 9038 and Brain Thrombosis

Article	Year
The regional cerebral blood flow amelioration of argatroban in the acute stage of cerebral thrombosis. The Keio journal of medicine, 2000, Volume: 49 Suppl 1 Topics: Acute Disease; Adult; Aged; Antithrombins; Arginine; Cerebrovascular Circulation; Female; Humans; Intracranial Thrombosis; Male; Middle Aged; Pipecolic Acids; Sulfonamides; Tomography, X-Ray Computed; Xenon	2000

Other Studies

2 other study(ies) available for mci 9038 and Brain Thrombosis

Article	Year
[Complex management of type 2 heparin-induced thrombocytopenia in patients with major bleeding tendency: two case report]. Annales de biologie clinique, 2020, Dec-01, Volume: 78, Issue:6 Topics: 4-Hydroxycoumarins; Aged; Anticoagulants; Arginine; Blood Coagulation Disorders; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Hemorrhage; Heparin; Humans; Indenes; Intracranial Thrombosis; Male; Middle Aged; Neurosurgical Procedures; Pipecolic Acids; Sulfonamides; Thrombocytopenia; Vitamin K	2020
Outcomes of Argatroban Treatment in Patients With Atherothrombotic Stroke: Observational Nationwide Study in Japan. Stroke, 2016, Volume: 47, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antithrombins; Arginine; Case-Control Studies; Cohort Studies; Female; Hemorrhage; Humans; Intracranial Arteriosclerosis; Intracranial Thrombosis; Japan; Male; Middle Aged; Odds Ratio; Pipecolic Acids; Practice Guidelines as Topic; Retrospective Studies; Stroke; Sulfonamides; Treatment Outcome	2016

Article

Year

[Complex management of type 2 heparin-induced thrombocytopenia in patients with major bleeding tendency: two case report].

Annales de biologie clinique, 2020, Dec-01, Volume: 78, Issue:6

Topics: 4-Hydroxycoumarins; Aged; Anticoagulants; Arginine; Blood Coagulation Disorders; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Hemorrhage; Heparin; Humans; Indenes; Intracranial Thrombosis; Male; Middle Aged; Neurosurgical Procedures; Pipecolic Acids; Sulfonamides; Thrombocytopenia; Vitamin K

2020

Outcomes of Argatroban Treatment in Patients With Atherothrombotic Stroke: Observational Nationwide Study in Japan.

Stroke, 2016, Volume: 47, Issue:2

Topics: Adult; Aged; Aged, 80 and over; Antithrombins; Arginine; Case-Control Studies; Cohort Studies; Female; Hemorrhage; Humans; Intracranial Arteriosclerosis; Intracranial Thrombosis; Japan; Male; Middle Aged; Odds Ratio; Pipecolic Acids; Practice Guidelines as Topic; Retrospective Studies; Stroke; Sulfonamides; Treatment Outcome

2016